SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10QSB - Optional form for quarterly and transition reports of small business issuers:
SEC Accession No. 0001321543-05-000080
Filing Date
2005-08-15
Accepted
2005-08-15 09:47:08
Documents
5
Period of Report
2005-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 193 maindoc.htm 10QSB 350321
2 CERTIFICATION ex31-1.htm EX-31.1 15204
3 CERTIFICATION ex31-2.htm EX-31.2 15175
4 CERTIFICATION ex32-1.htm EX-32.1 8354
5 CERTIFICATION ex32-2.htm EX-32.2 8552
  Complete submission text file 0001321543-05-000080.txt   399153
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 001-15070 | Film No.: 051023759
SIC: 2834 Pharmaceutical Preparations